Episode 17. CBD with Dr Sud Agarwal

Medical cannabinoids are derived from the cannabis sativa plant. There are 144 known cannabinoids, THC is perhaps the best known for its psycho-active effects, however cannabidiol (CBD) is now being recognised for its many medical applications. To discuss the role of cannabidiol in medicine we are joined by Dr Sud Agarwal, anaesthetist and CEO of one of Australia’s most interesting and emerging biotechs called Cannvalate. In this episode, Sud discusses the uses of CBD -

· as an anticonvulsant and neuroprotective agent

· as an anti-inflammatory and

· as an immunomodulator

Sud also takes us on his journey to becoming seriously involved in the biotech industry. Please enjoy this episode with the very colourful and energetic Dr Sud Agarwal.

Useful references include –

www.cannvalate.com.au

www.compassclinics.com.au

www.ncbi.nlm.nih.gov

To be a guest on the show or provide some feedback, I’d love to hear from you: manager@gihealth.com.au

Dr Luke Crantock MBBS, FRACP, is a gastroenterologist in practice for over 25 years. He is the founder of The Centre for GI Health, based in Melbourne Australia and is passionate about educating General Practitioners and patients on disease prevention and how to manage and improve their digestive health.

Previous
Previous

Episode 18. Voluntary Assisted Dying (VAD) with Dr Frank Hofmann

Next
Next

Episode 16. Trauma Courses with Dr Tom Edgley